Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1200 of 2026 entries
View as:

A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT02019290 Org: User:
Start: 02/10/14 End: 03/31/14 Due: 03/31/15

A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01941095 Org: User:
Start: 11/20/13 End: 07/10/16 Due: 07/10/17

A Study of RO4917838 With Rosuvastatin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01183585 Org: User:
Start: 08/31/10 End: 09/30/10 Due: 09/30/11

ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00925769 Org: User:
Start: 01/31/09 End: 12/31/13 Due: 12/31/14

Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT02716779 Org: User:
Start: 04/30/07 End: 04/30/10 Due: 04/30/11

An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03155347 Org: User:
Start: 08/02/17 End: 08/08/22 Due: 08/08/23

A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05307679 Org: User:
Start: 12/16/22 End: 03/04/24 Due: 03/04/25

A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT01513083 Org: User:
Start: 02/29/12 End: 09/30/14 Due: 09/30/15

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04552899 Org: User:
Start: 03/19/21 End: 02/10/23 Due: 02/10/24

SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).

Phase: N/A Priority: Normal
NCT ID: NCT00442572 Org: User:
Start: 07/03/06 End: 04/23/12 Due: 04/23/13

A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT03281369 Org: User:
Start: 10/13/17 End: 09/30/25 Due: 09/30/26

A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00377442 Org: User:
Start: 08/31/06 End: 04/30/07 Due: 04/30/08

A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT02720120 Org: User:
Start: 10/31/05 End: 02/28/13 Due: 02/28/14

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Phase: N/A Priority: Normal
NCT ID: NCT00412555 Org: User:
Start: 12/31/06 End: 05/31/07 Due: 05/31/08

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04475848 Org: User:
Start: 07/15/20 End: 02/06/22 Due: 02/06/23

A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)

Phase: N/A Priority: Normal
NCT ID: NCT02780622 Org: User:
Start: 02/29/08 End: 07/31/08 Due: 07/31/09

A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab

Phase: N/A Priority: Normal
NCT ID: NCT01338558 Org: User:
Start: 06/30/11 End: 05/31/15 Due: 05/31/16

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Phase: N/A Priority: Normal
NCT ID: NCT00423501 Org: User:
Start: 02/28/07 End: 11/30/07 Due: 11/30/08

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04165135 Org: User:
Start: 02/24/20 End: 04/28/22 Due: 04/28/23

A Study of the Effect of Multiple Doses of Itraconazole and Fluoxetine on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01967979 Org: User:
Start: 10/31/13 End: 12/31/13 Due: 12/31/14

A Study of RG7625 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02295332 Org: User:
Start: 12/31/14 End: 04/30/15 Due: 04/30/16

An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01340443 Org: User:
Start: 01/19/11 End: 07/15/16 Due: 07/15/17

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Phase: N/A Priority: Normal
NCT ID: NCT01677780 Org: User:
Start: 11/28/12 End: 06/26/17 Due: 06/26/18

A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT01115491 Org: User:
Start: 06/30/10 End: 07/31/12 Due: 07/31/13

A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.

Phase: N/A Priority: Normal
NCT ID: NCT00502996 Org: User:
Start: 02/28/06 End: 12/31/08 Due: 12/31/09